首頁 › 過重 › 德克薩斯州 › San Antonio
San Antonio, TX 的 過重 臨床試驗
34 項針對 過重 的研究正在 San Antonio（約 30 英里範圍內）及其周邊地點尋找參與者。開啟研究以查看參與資格及聯絡研究團隊的方式。
官方研究文本（英文）
正在為研究招募對象嗎？將此頁面置頂展示 — $99 / 30 天 →
A Study to Evaluate the Impact of Renal Impairment on the Pharmacokinetics (PK) of Ribupatide
招募中1 期歡迎健康志工
- Kailera Clinical Site, San Antonio
A Research Study on How Well Cagrilintide and CagriSema Work in Children and Adolescents With Excess Body Weight
招募中3 期
- DM Clinical, San Antonio
- The Texas Liver Institute, San Antonio
- Pinnacle Clinical Research, San Antonio
- 還有 1 項
Study of ALV-100 to Assess Safety, Tolerability, and PK/PD in Overweight/Obese Participants With or Without T2D
招募中1 期
- Endeavor Clinical Trials, San Antonio
A Research Study Investigating How Well the Medicine Zenagamtide Helps People With Excess Body Weight Lose Weight Compared to Semaglutide
招募中3 期
- Sleep Therapy Research Center, San Antonio
A Study of Orforglipron in Participants With Overweight at Risk of Development of Obesity-Related Complications or Progression to Class 1 Obesity
招募中3 期
- IMA Clinical Research San Antonio, San Antonio
- VIP Trials, San Antonio, TX 78230
- Consano Clinical Research, LLC, Shavano Park · 距離 12 英里
A Study to Learn About the Study Medicine Called Berobenatide (PF-08653944) in People With Overweight or Obesity
招募中3 期
- VIP Trials, San Antonio
Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight
招募中3 期
- Gastroenterology Research of San Antonio, San Antonio
- Southern Star Research Institute, San Antonio
Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study
招募中3 期
- Gastroenterology Research of San Antonio, San Antonio
- Southern Star Research Institute, San Antonio
A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, and Type 2 Diabetes
招募中3 期
- IMA Clinical Research San Antonio, San Antonio
A Study of Eloralintide (LY3841136) in Participants With Persistent Obesity Who Are Treated With a Weekly Incretin
招募中3 期
- IMA Clinical Research San Antonio, San Antonio
- Endeavor Clinical Trials, San Antonio
- Consano Clinical Research, LLC, Shavano Park · 距離 12 英里
A Study to Evaluate Effect of AZD6234 in Adult Participants With Type 2 Diabetes Mellitus and Obesity or Overweight
招募中3 期
- Research Site, San Antonio
- Research Site, San Antonio
- Research Site, San Antonio
A Study of Eloralintide (LY3841136) in Participants With Obstructive Sleep Apnea and Obesity or Overweight
招募中3 期
- Sleep Therapy Research Center, San Antonio
- Consano Clinical Research, LLC, Shavano Park · 距離 12 英里
Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity
招募中3 期
- Bandera Family Health Care, San Antonio
- Consano Clinical Research - Shavano Park, Shavano Park · 距離 12 英里
A Study of Eloralintide (LY3841136) in Participants With Obesity, or Overweight Without Type 2 Diabetes
招募中3 期
- IMA Clinical Research San Antonio, San Antonio
Efficacy and Safety of Eloralintide (LY3841136) in Participants With Osteoarthritis Knee Pain and Obesity or Overweight
招募中3 期
- VIP Trials, San Antonio
- Endeavor Clinical Trials, San Antonio
- Consano Clinical Research, LLC, Shavano Park · 距離 12 英里
A Study to Investigate Weight Management With Macupatide and Eloralintide, Alone or in Combination, in Adult Participants With Obesity or Overweight
招募中2 期
- Endeavor Clinical Trials, San Antonio
A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Weight-Related Comorbidities
招募中3 期
- AURORA-1 Clinical Site, San Antonio
- AURORA-1 Clinical Site, San Antonio
A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Type 2 Diabetes
招募中3 期
- AURORA-2 Clinical Site, San Antonio
- AURORA-2 Clinical Site, San Antonio
A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight and Type 2 Diabetes
招募中3 期
- Pinnacle Clinical Research - San Antonio, San Antonio
A Study of LY3457263 Compared With Placebo in Participants With Type 2 Diabetes on a Stable Dose of Semaglutide or Tirzepatide
招募中2 期
- Consano Clinical Research, LLC, Shavano Park · 距離 12 英里
A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight Without Type 2 Diabetes
招募中3 期
- Pinnacle Clinical Research - South San Antonio, San Antonio
- IMA Clinical Research - San Antonio, San Antonio
- Consano Clinical Research, Shavano Park · 距離 12 英里
AMAZE 3: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Obstructive Sleep Apnoea Not Treated With Positive Airway Pressure Lose Weight and Improve Sleep Apnoea
招募中3 期
- Sleep Therapy Research Center, San Antonio
A Study of Aleniglipron in Adults With Obesity or Overweight and Type 2 Diabetes Mellitus (ACCOMPLISH-2)
招募中3 期歡迎健康志工
- ACCOMPLISH-2 Research Site, San Antonio
- ACCOMPLISH-2 Research Site, San Antonio
AMAZE 4: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Obstructive Sleep Apnoea Treated With Positive Airway Pressure Lose Weight and Improve Sleep Apnoea
招募中3 期
- Sleep Therapy Research Center, San Antonio
A Master Protocol Study (LY900038) of Multiple Intervention-Specific-Appendices (ISAs) in Adult Participants With Obesity or Overweight
招募中2 期
- Endeavor Clinical Trials, San Antonio
A Study of Macupatide (LY3532226) and Eloralintide (LY3841136), Alone or in Combination, in Adults With Obesity or Overweight and With Type 2 Diabetes
招募中2 期
- Consano Clinical Research, LLC, Shavano Park · 距離 12 英里
A First-in-human Research Study on How NNC0721-8060 Works in People Living With Overweight or Obesity
招募中1 期歡迎健康志工
- ICON, San Antonio
A Study to Investigate the Effectiveness of Tirzepatide (LY3298176) Following Initiation of Ixekizumab (LY2439821) in Participants With Moderate-to-Severe Plaque PsO and Obesity or Overweight in Clinical Practice (TOGETHER AMPLIFY-PsO)
招募中4 期
- Texas Dermatology and Laser Specialists, San Antonio
Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-1-EXTENSION)
招募中3 期
- Clinical Trials of Texas, San Antonio
A Study of LY4174794 in Participants With Obesity or Overweight Who Are Otherwise Healthy
招募中1 期歡迎健康志工
- ICON Early Phase Services, LLC, San Antonio
Efficacy, Safety and Tolerability of Switching From Glucagon-like Peptide-1 Receptor Agonists (GLP-1RA) to Maridebart Cafraglutide in Adults With Obesity or Overweight (MARITIME-SWITCH)
招募中3 期
- VIP Trials, San Antonio
A Study to Evaluate Effect of AZD6234 in Adult Participants With Obesity or Overweight With Weight-related Comorbidity Without Type 2 Diabetes Mellitus
招募中3 期
- Research Site, San Antonio
A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight
招募中1 期歡迎健康志工
- ICON Early Phase Services, San Antonio
Efficacy and Safety of Aleniglipron in Participants With Obesity or Overweight With a Weight-Related Comorbidity (ACCOMPLISH-1)
招募中3 期
- ACCOMPLISH-1 Research Site, San Antonio
其他城市的 過重 試驗
- Houston, TX33 項研究
- Chicago, IL28 項研究
- Orlando, FL27 項研究
- Las Vegas, NV23 項研究
- Miami, FL23 項研究
- Atlanta, GA20 項研究
- Dallas, TX20 項研究
- New York City, NY19 項研究
- Jacksonville, FL19 項研究
- Washington, DC19 項研究
- Austin, TX18 項研究
- Baltimore, MD17 項研究
San Antonio 的其他研究
- 非小細胞肺癌59 項研究
- 大腸直腸癌46 項研究
- 乳癌46 項研究
- 轉移性癌症44 項研究
- 癌症（所有類型）41 項研究
- 肥胖症40 項研究
- 第二型糖尿病37 項研究
- 卵巢癌31 項研究
- 胰臟癌31 項研究
- 前列腺癌28 項研究
- 子宮內膜癌27 項研究
- 肺癌26 項研究
資料來源：ClinicalTrials.gov，擷取日期 2026年10月5日。各研究自行設定資格標準；由研究團隊決定參與者資格。